NIH-funded research NIH-funded research

Investigating how certain brain chemicals affect fear memory in PTSD

Official title: The role of cerebellar endocannabinoids in the reconsolidation and extinction of fear memory

Funded at Southeast Louisiana Veterans Health Care · NIH-10951490 · Data updated 2026-11-12

This study is looking at how certain natural chemicals in the brain can help people with PTSD change their fear memories, with the hope of finding new ways to help those who haven't had success with regular treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSoutheast Louisiana Veterans Health Care
NIH-funded
Lab location1 site (New Orleans, United States)
Project startOctober 1, 2023
Project endSeptember 30, 2027
Funding year2025
NIH project number5I01BX006043-02
Project IDNIH-10951490 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are veterans or individuals experiencing PTSD who struggle with persistent fear responses.

Less likely to help

Patients without PTSD or those who do not have a history of trauma may not receive any benefit from this research.

What this research studies

This research focuses on understanding how endocannabinoids in the cerebellum influence the processes of fear memory reconsolidation and extinction in individuals with post-traumatic stress disorder (PTSD). By exploring the mechanisms behind fear responses and how they can be modified, the study aims to identify new therapeutic approaches for patients who do not respond to traditional treatments. The methodology involves examining the brain's response to fear stimuli and testing potential interventions that could disrupt harmful fear memories. This could lead to innovative treatments that help patients learn to manage their fear responses more effectively.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve the treatment of PTSD, particularly for those who have not benefited from existing methods.

How similar studies have gone: While there has been extensive research on fear memory and its treatment, this specific approach focusing on cerebellar endocannabinoids is relatively novel and has not been widely tested.

Where this research is happening

  • Southeast Louisiana Veterans Health Care
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Liu, Siqiong June — Southeast Louisiana Veterans Health Care
  • Study coordinator: Liu, Siqiong June

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.